1. ASTHO (Association of State and Territorial Health Officials) Operational framework for partnering with pharmacies for administration of 2009 H1N1 vaccine. Sep 28, 2009. [accessed August 6, 2010]. http://www​.astho.org​/Display/AssetDisplay.aspx?id=2613.
  2. CDC (Centers for Disease Control and Prevention) Emergency MedKit Evaluation Study Summary. Nov 15, 2007. [accessed August 2, 2010]. http://www​.bt.cdc.gov​/agent/anthrax/prep​/pdf/medkit-evaluation-summary-2007.pdf.
  3. CDC. Cities Readiness Initiative. 2010a. [accessed August 2, 2010]. http://www​.bt.cdc.gov/cri/
  4. Strategic National Stockpile. CDC. 2010b. [accessed August 2, 2010]. http://www​.bt.cdc.gov/stockpile/
  5. CDC. Estimates of deaths associated with seasonal influenza—United States, 1976–2007. Morbidity and Mortality Weekly Report. 2010c;59(33):1057–1062. [PubMed: 20798667]
  6. CDC. History of flu pandemics. 2010d. [accessed, August 27, 2010]. http://www​.flu.gov/individualfamily​/about/pandemic/history​.html.
  7. CDC. Coverage under the Public Readiness and Emergency Preparedness (PREP) Act for H1N1 vaccination. 2010e. [accessed August 25, 2010]. http://www​.flu.gov/professional​/federal/vaccineliability​.html.
  8. CDC. Termination of the Emergency Use Authorization (EUA) of medical products and devices. 2010f. [accessed August 2, 2010]. http://www​.cdc.gov/h1n1flu/eua.
  9. DHS (Department of Homeland Security) Memorandum from Michael Chertoff to Michael O. Leavitt, Determination Pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act. Sep 23, 2008. [accessed August 5, 2010]. http://bioterrorism​.slu​.edu/education/projects​/EQUIPPDocs/Chertoff.pdf.
  10. FDA (Food and Drug Administration) SOPP 8010: Administrative procedures for Emergency Use Authorization of medical products. 2005. [accessed August 2, 2010]. http://www​.fda.gov/BiologicsBloodVaccines​/GuidanceComplianceRegulatoryInformation​/ProceduresSOPPs/ucm061226.Htm.
  11. FDA. Emergency Use Authorization of medical products: Guidance. Jul, 2007. [accessed July 5, 2010]. http://www​.fda.gov/RegulatoryInformation​/Guidances/ucm125127.htm#publication.
  12. FDA. Letter of Emergency Use Authorization for the pre-event provision and potential use of doxycycline hyclate tablet emergency kits for inhalational anthrax. Feb 5, 2008. [accessed August 5, 2010]. http://www​.fda.gov/downloads​/Drugs/EmergencyPreparedness​/BioterrorismandDrugPreparedness/UCM107309​.pdf.
  13. FDA. Authorizations of emergency use of certain antiviral drugs–zanamivir and oseltamivir phosphate. Federal Register. 2010a;74(148):38648–38654.
  14. FDA. Authorization of emergency use of the antiviral product peramivir accompanied by emergency use information. Federal Register. 2010b;74(210):56644–56649.
  15. FDA. Authorization of emergency use of certain personal respiratory protection devices. Federal Register. 2010c;74(148):38644–38648.
  16. FDA. Medical devices and flu emergencies: Historical information. 2010d. [accessed August 25, 2010]. http://www​.fda.gov/MedicalDevices​/Safety​/EmergencySituations/ucm161496.htm.
  17. HHS (U.S. Department of Health and Human Services) Project BioShield. 2010a. [accessed August 2, 2010]. https://www​.medicalcountermeasures​.gov/BARDA​/bioshield/bioshield.aspx.
  18. HHS. Public Readiness and Emergency Preparedness Act. 2010b. [accessed August 2, 2010]. http://www​.phe.gov/preparedness​/legal/prepact/Pages/default​.aspx.
  19. HRSA (Health Resources and Services Administration) Public Readiness and Emergency Preparedness Act Countermeasures Injury Compensation Program, procedures for submitting a letter of intent to file requests for benefits. Federal Register. 2010a May 12;75(91):26773–26774.
  20. HRSA. Countermeasures Injury Compensation Program. 2010b. [accessed August 25, 2010]. http://www​.hrsa.gov/gethealthcare​/conditions​/countermeasurescomp/index.html.
  21. IOM (Institute of Medicine) Dispensing medical countermeasures for public health emergencies: Workshop summary. Washington, DC: The National Academies Press; 2008.
  22. IOM. The Public Health Emergency Medical Countermeasures Enterprise: Innovative strategies to enhance products from discovery through approval: Workshop summary. Washington, DC: The National Academies Press; 2010a. [PubMed: 22171399]
  23. IOM. The 2009 H1N1 influenza vaccination campaign: Summary of a workshop series. Washington, DC: The National Academies Press; 2010b. [PubMed: 21595118]
  24. NABP (National Association of Boards of Pharmacy) Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy. Aug, 2010. [accessed October 29, 2010]. http://www​.nabp.net/publications​/assets/ModelAct.doc.
  25. NACCHO (National Association of County and City Health Officials) Local health department job losses and program cuts: Findings from January/February 2010 survey. May, 2010. [accessed July 2, 2010]. http://www​.naccho.org​/topics/infrastructure​/lhdbudget/upload​/Job-Losses-and-Program-Cuts-5-10.pdf.
  26. Sherman SE, Foster J, Vaid S. Emergency Use Authorization and the 2009 H1N1 influenza. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 2009;7(3):245–250. [PubMed: 19821747]
  27. Trust for America’s Health. Shortchanging America’s health: A state-by-state look at how public health dollars are spent and key state health facts. Mar, 2010. [accessed July 2, 2010]. http:​//healthyamericans​.org/assets/files​/TFAH2010Shortchanging05.pdf.
  28. The White House. Executive Order—medical countermeasures following a biological attack. Dec 30, 2009. [accessed August 2, 2010]. http://www​.whitehouse​.gov/the-press-office​/executive-order-medical-countermeasures-following-a-biological-attack.